IASLC Reviewer Workshop | IASLC
Improving Reviewer Performance.
Improving Reviewer Performance.
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and…
The association seeks input from members to better understand the current DEI landscape so it can continue to build a diverse international community dedicated to…
The filing was based on results from a global phase III study designed to compare the ALK inhibitor to crizotinib in the first-line treatment of…
Profs. Jan von der Thüsen and John Le Quesne say while still in the early phases, AI has the potential to bring accessible and affordable…
Drs. Matthew Lee, Benjamin Levy, and Balazs Halmos say several key issues need to be addressed before this class of agents can achieve wider impact.
As part of the IASLC’s 2024 DEI Initiative, the association is gathering member insights through an online survey and a series of virtual focus groups…
This survey is intended to better understand your membership experience at IASLC as it relates to diversity, equity, inclusion, and accessibility. We want to explore…
Drs. Matthew Lee, Benjamin Levy, and Balazs Halmos say several key issues need to be addressed before this class of agents can achieve wider impact.
During the European Lung Cancer Congress, Dr. Natalia Valdiviezo presented the data, which favored frontline osimertinib plus chemotherapy compared to osimertinib alone for patients with…
Part 2 of our podcast coverage on ESMO 2023 includes an in-depth interview with Dr. Jarushka Naidoo on early-stage NSCLC, including updates from CHECKMATE 816,…